Ceptaris Therapeutics
Ceptaris Therapeutics is a pharmaceutical company developing therapeutics for symptoms of early-stage mycosis fungoides.
Funding reportedLast round: Series D
Follow Ceptaris Therapeutics and see its new rounds in your feed.Start following
What company datasets say Ceptaris Therapeutics raised
Funding, as reported
Reported in all64.8Min the source's currency
Rounds10
Last roundSeries D
Last round dateJun 2012
Investors listed12
On a portfolio page
Investors who name them
Each firm lists Ceptaris Therapeutics on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.
How it ended, so far
Exit
ExitBuyerPriceWhen
AcquiredActelion Pharmaceuticals$250MJul 2013
Biotechnology in the same market
Startups like it
Is this your company?
Add your raise, your deck and your story, and put Ceptaris Therapeutics in front of investors. Or tell us what we have wrong.